Detalles de la búsqueda
1.
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
N Engl J Med
; 356(19): 1928-43, 2007 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17494926
2.
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women.
Int J Cancer
; 122(6): 1311-8, 2008 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18000825
3.
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.
Lancet
; 369(9574): 1693-702, 2007 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-17512854
4.
Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children.
Pediatr Infect Dis J
; 21(10): 910-7, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12394811
5.
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.
J Acquir Immune Defic Syndr
; 55(2): 197-204, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20574412
6.
Impact of a quadrivalent HPV6/11/16/18 vaccine in Mexican women: public health implications for the region.
Arch Med Res
; 40(6): 514-24, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19853193
7.
Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines.
Vaccine
; 26(5): 686-96, 2008 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-18164106
8.
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines.
Clin Vaccine Immunol
; 14(6): 792-5, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17428949
9.
Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.
Pediatrics
; 118(5): 2135-45, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17079588
10.
HPV vaccine continues to be safe and effective, and its benefits continue to outweigh its risks.
Expert Rev Vaccines
; 9(7): 697-701, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20624041
Resultados
1 -
10
de 10
1
Próxima >
>>